Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects
Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects
复制标题
DOI:
10.1089/met.2018.0066
复制
发表时间:
2018-10-16
影响因子:
2.1
通讯作者:
Knop, Filip K.
中科院分区:
文献类型:
--
作者:
Demant, Mia;Bagger, Jonatan I.;Knop, Filip K.
Background: Fasting hyperglucagonemia can be detrimental to glucose metabolism in patients with type 2 diabetes (T2D) and may contribute to metabolic disturbances in obese and/or prediabetic subjects. However, the mechanisms underlying fasting hyperglucagonemia remain elusive. Methods: We evaluated the interrelationship between fasting hyperglucagonemia and demographic and biochemical parameters in 106 patients with T2D (31% female, age: 579 years [meanstandard deviation; body mass index (BMI): 30.1 +/- 4.4kg/m(2); fasting plasma glucose (FPG): 9.61 +/- 2.39mM; hemoglobin A1c (HbA1c): 57.1 +/- 13.1mmol/mol] and 163 nondiabetic control subjects (29% female; age: 45 +/- 17 years; BMI: 25.8 +/- 4.1kg/m(2); FPG: 5.2 +/- 0.4mM; and HbA1c: 35.4 +/- 3.8mmol/mol). Multiple linear regression analysis was applied using a stepwise approach with fasting plasma glucagon as dependent parameter and BMI, waist-to-hip ratio (WHR), blood pressure, hemoglobin A1c, FPG, and insulin concentrations as independent parameters. Results: Fasting plasma glucagon concentrations were significantly higher among patients with T2D (13.5 +/- 6.3 vs. 8.5 +/- 3.8mM, P